May 24-25, 2022
Virtual Event
View the agenda and register now!
Understanding the immune response as a clinical development team is required in the development of biologics. This workshop covers key aspects of the assessment of immune response considerations in discovery and preclinical studies, from the clinical stages through approval. It is organized along the phases of drug development and uses case-study based presentations to demonstrate challenges and best practices. Discuss the current thinking on hot topics, including the appropriate approach for assessments in non-clinical trials; developing immunogenicity assays for novel constructs; developing immunogenicity risk assessments for clinical development; and current expectations for assay validations.
Learning Objectives:
- Develop a better understanding of key challenges and critical steps to understanding immunogenicity to maximize success in clinical development programs.
- Gain an understanding of the immunogenicity challenges across disciplines outside of your own expertise.
- See how the challenges of immunogenicity relate to each stage of the drug development process.
- Prepare to work with development teams to troubleshoot unexpected immunogenicity problems.
Learn more and register for this workshop!